ROYAL BANK OF CANADA - MAXCYTE INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of MAXCYTE INC
ValueSharesWeighting
Q3 2023$49,000
+16.7%
15,769
+72.1%
0.00%
Q2 2023$42,000
+68.0%
9,162
+80.7%
0.00%
Q1 2023$25,000
-61.5%
5,071
-57.2%
0.00%
Q4 2022$65,000
+712.5%
11,844
+866.9%
0.00%
Q3 2022$8,000
+166.7%
1,225
+87.0%
0.00%
Q2 2022$3,000
-93.2%
655
-89.6%
0.00%
Q1 2022$44,000
-78.9%
6,306
-69.3%
0.00%
Q4 2021$209,000
+808.7%
20,509
+972.6%
0.00%
Q3 2021$23,0001,9120.00%
Other shareholders
MAXCYTE INC shareholders Q4 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,225,000$20,963,0008.46%
NORTH RUN CAPITAL, LP 556,960$3,620,0007.35%
Vitruvian Partners LLP 5,043,356$32,782,0005.85%
Casdin Capital, LLC 10,735,786$69,783,0004.58%
RIVER GLOBAL INVESTORS LLP 1,867,113$11,880,0002.28%
APIS CAPITAL ADVISORS, LLC 200,000$1,300,0001.95%
Pier Capital, LLC 1,262,654$8,207,0001.41%
Montanaro Asset Management Ltd 929,000$6,009,0000.92%
First Light Asset Management, LLC 1,362,543$8,857,0000.90%
Grandeur Peak Global Advisors, LLC 1,206,013$7,839,0000.48%
View complete list of MAXCYTE INC shareholders